Application of Platelet-rich Plasma in Pilonidal Sinus Disease
1 other identifier
interventional
63
1 country
1
Brief Summary
Pilonidal sinus disease is a common health-care problem, and surgical excision is the standard treatment modality. Controversy still exists regarding the best surgical technique for treating pilonidal disease in terms of minimizing disease recurrence and patient discomfort. In this study, the investigators compared the impact of autologous platelet-rich plasma (PRP) with that of minimally invasive techniques on pain reduction, return to daily activities, quality of life, and duration of wound healing after open excision and secondary closure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
January 1, 2021
CompletedFirst Posted
Study publicly available on registry
January 6, 2021
CompletedJanuary 6, 2021
January 1, 2021
10 months
January 1, 2021
January 4, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Wound Healing
Wound healing rate was evaluated as recovery time per the cavity volume (day/cc). This showed the time required for each 1 cc volume of the cavity to be filled on a daily basis. After open or minimally invasive surgery, the volume of the cavity was measured with saline solution. The cavity was filled with saline and the volume of the cavity was determined by calculating how much fluid it took. The measurements were performed on postoperative days 0, 2, 3, 4 and 21. Therefore recovery time per the cavity volume was calculated according to the differences between the measurements.
on postoperative days 0, 2, 3, 4 and 21
Secondary Outcomes (2)
Visual Analog Scale (VAS) score
at 24th hour, 48th hour, 96th hour, 120th hour and 3rd week
Short Form-36 and Nottingham Health Profile
before the surgery and in the postoperative 3rd week
Study Arms (3)
Group A
PLACEBO COMPARATORThe open surgical method and a moist gauze (with saline) were applied to patients in group A
Group B
EXPERIMENTALOpen surgery and then PRP application were performed on patients in group B. After the cavity was filled with PRP, the wound was covered with a dry gauze.
Group C
EXPERIMENTALPRP was applied to the patients in group C after curettage of the sinus cavity. And again the wound was covered with a dry gauze.
Interventions
Each patient entered the operating room, and after the administration of general anaesthesia, the patient was placed in the prone position. Then, the buttocks were stretched to the lateral sides using adhesive bands to remove the disease area. The sacrococcygeal region was cleaned and disinfected with 10% povidone iodine. After covering the area around the region, the sinus tract was examined by using a thin-steel cane. The length and wealth of the cavity were noted. Then, the sinus tract was removed. The depth of the cavity was noted. Then, 50 cc of 0.9% saline solution (SS) was taken into a syringe and applied to the cavity until it filled the whole space, allowing the cavity volume to be measured accurately. The measurement was performed by subtracting the remaining saline-solution volume in the syringe from the whole syringe volume, which was 50 cc.
In the operating room, after the patient was placed in the prone position, the region was removed by stretching the buttocks with adhesive bands and cleaning the area with 10% povidone iodine. The largest pit was excised, and hairs in the cavity were removed with forceps. Then, the whole cavity was curetted meticulously and irrigated with SS. After haemostasis, the cavity volume was measured
Platelet rich plasma (PRP) was administered by filling the whole space from the lateral side of the cavity. After the first implementation of PRP, the second one was applied at 48 hours. Until that time, the dressing was not uncovered. PRP was applied on the 3rd, 4th and 5th days postoperatively.
Eligibility Criteria
You may qualify if:
- chronic pilonial sinus disease
- patients who had undergone abscess drainage and remained diseased after 8-10 weeks of drainage
You may not qualify if:
- patients with acute abscess
- patients with anemia
- patients that use immunosuppressive drugs
- patients with haematological malignancy
- patients with bleeding disorder
- patients with recurrent pilonida sinus disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cihangir Akyollead
Study Sites (1)
Ankara University School of Medicine Department of General Surgery
Ankara, 06100, Turkey (Türkiye)
Related Publications (1)
Boztug CY, Karaagac Akyol T, Benlice C, Koc MA, Doganay Erdogan B, Ozcebe OI, Kuzu MA, Akyol C. Platelet-rich plasma treatment improves postoperative recovery in patients with pilonidal sinus disease: a randomized controlled clinical trial. BMC Surg. 2021 Oct 21;21(1):373. doi: 10.1186/s12893-021-01370-5.
PMID: 34670534DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Can Y Boztug, MD
Ankara University School of Medicine Departmernt of General Surgery
- STUDY CHAIR
Cihangir Akyol, MD
Ankara University School of Medicine Departmernt of General Surgery
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associate Proffessor
Study Record Dates
First Submitted
January 1, 2021
First Posted
January 6, 2021
Study Start
March 1, 2018
Primary Completion
January 1, 2019
Study Completion
July 1, 2019
Last Updated
January 6, 2021
Record last verified: 2021-01
Data Sharing
- IPD Sharing
- Will not share